Please read our privacy policy before using our website. If you continue to use our website, you imply acceptance of the data privacy declaration.
During this year’s virtual ECR 2020, we provided an insight into data-driven radiology with our Mint in 30 Minutes webcast. Using live software showcases, our colleagues demonstrated how to acquire structured data, how to visualize it, and how to export it by using mint Lesion™,…
Mint Medical is on the front lines in the fight against COVID-19, proving that radiology can act as a role model for gathering evidence by utilizing structured data. In this webcast, Prof. Dr. Maria-Katharina Ganten and Gabriel Salg highlight the urgent need for structured…
Funded by the German Federal Ministry of Education and Research, the ExploreCOVID project aims to analyze patient history and clinical as well as imaging data across multiple medical centers to identify standardizable diagnostic criteria. By doing so, a comprehensive database of structured data will be…
In a recent webcast, Dr. Ronald Korn, Founder and CMO at Imaging Endpoints and Kelie Williams Luby, VP Clinical Trials Software at Mint Medical, presented an integrated, comprehensive analysis using the mint Lesion™ platform for a seamless evaluation of COVID-19 patients and trials. Together they…
From my initial experience with mint Lesion software, and over the 3 months I have been using it, I have been pleased with the software and come to depend on it. Assessing tumor response to therapy involves a myriad of details that are distinct…
Funded by the National Institute of Health Research (NIHR) and sponsored by Imperial College London, the MROC study boasts impressive figures: 645 women with suspected or confirmed ovarian cancer (over 400 recruited to date), 18 patient recruitment sites across UK and 4 additional external review…
Since the beginning of 2017, all PI-RADS v2 reads are exclusively performed with mint Lesion by PD Dr. Matthias Röthke, Chief Medical Officer at Conradia in Hamburg (see exemplary Mint report here). In this interview he outlines the challenges of prostate cancer assessment and how Mint…
